My watch list
my.bionity.com  
Login  

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris and in New York.

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than a billion doses of vaccine in 2006, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The Company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR1 million in research and development.

One of the world's leading pharmaceutical companies and number 1 in Europe.

Our major therapeutic areas : Cardiovascular, thrombosis, metabolic disorders, oncology, central nervous system, internal medicine and vaccines.

About 100,000 employees worldwide. Sales force of 35,000 medical visitors.

Present in 100 countries throughout the 5 continents. Consolidated sales of 28 billion euros and more than 4 billion euros Research & Development.

5,3% Market share.

More about Sanofi-Aventis
  • News

    Sanofi sells European generics business

    Advent International and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi's European generics business for €1,9 billion. Advent's offer is firm, binding and fully financed. Advent is a global investor, with over 25 years' experience of investi ... more

    Sanofi to invest €350 million in Canadian vaccine facility

    Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public ... more

    Sanofi's Board of Directors proposes appointment of Emmanuel Babeau as new independent director

    Sanofi's Board of Directors proposed to submit the appointment of Emmanuel Babeau as new independent director, as well as the renewal of the terms of Olivier Brandicourt, Patrick Kron and Christian Mulliez to a shareholders' vote during the general shareholders' meeting on May 2, 2018. Robe ... more

  • Companies

    Sanofi-Aventis Deutschland GmbH

    Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris and in New York. Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than a billi ... more

    sanofi-aventis Groupe

    One of the world's leading pharmaceutical companies and number 1 in Europe. Sanofi-aventis' pharmaceuticals business focuses on six therapeutic areas: diabetes, oncology, thrombosis, cardiovascular diseases, central nervous system (CNS) and internal medicine. About 100,000 employees worl ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE